Peer Review History

Original SubmissionJuly 7, 2025
Decision Letter - Wei Wu, Editor

Dear Dr. Lomarat,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Oct 19 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Wei Wu

Academic Editor

PLOS ONE

Journal Requirements:

1. When submitting your revision, we need you to address these additional requirements.-->--> -->-->Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at -->-->https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and -->-->https://journals.plos.org/plosone/s/file?id=ba62/PLOSOne_formatting_sample_title_authors_affiliations.pdf-->--> -->-->2. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. ?>

Additional Editor Comments:

1, Although the manuscript suggests that intraoperative TEE was performed in all included cases, this point is not consistently or clearly stated. Given that the primary outcome relates directly to TEE’s influence on surgical planning, it is essential to clearly document the TEE rate and whether it was applied uniformly to all patients. In addition, the manuscript would benefit from more clarity on patient selection, flow, and subgroup structure. For example, it remains somewhat confusing how the subgroups (e.g., TTE-only, TEE-only, or both) were formed, and whether TEE indications were predefined or at the discretion of the care team.

2, The lack of postoperative outcome analysis limits the ability to fully assess the clinical impact of TEE-guided surgical plan changes. While this may have been outside the original scope, the inclusion of even limited outcome data (e.g., 30-day mortality, complication rates, or length of stay) would substantially strengthen the conclusions and may be feasible from prospective dataset.

Reviewers' comments:

Comments to the Author

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Partly

**********

2. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: No

**********

3. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

**********

4. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: # Summary

1. These investigators conducted a prospective observational study to investigate the impact of intraoperative TEE on surgical planning (primary outcome) and wait times (secondary outcome), among 624 cardiac surgical patients undergoing surgery the calendar year of 2023. They found intraoperative TEE altered the surgical plan in 10% of cases, but did not study clinical outcomes.

# Overall Assessment

1. This is important work on the impact of TEE in a resource-limited situation. However, the absence of investigating TEE's impact on postsurgical outcomes limits the impact and makes this study largely descriptive.

# Major Issues / Questions

1. what was the overall rate of intraoperative TEE? I see the rate of preoperative TEE was only 15% but I don't see intraoperative TEE reported. If intraoperative TEE was performed in only 15% of cases, there is a major selection bias and residual confounding is likely present. At a minimum matching would be necessary and could consider 1:2 or even 1:3 matching if TEE rate is truly only 15%.

2. While a change in surgical plan is important, it would be stronger if there were an associated postoperative outcomes analysis (e.g. lower rates of reoperation, stroke, complications, death, etc. with TEE)?

# Minor Issues

1. The terminology needs to be consistent. Decide on "perioperative" or "intraoperative" TEE and keep it consistent throughout.

2. Consider limiting the analysis to intraoperative TEE (instead of adding TTE and the wait times). It starts to become confusing to the reader to interpret.

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/ . PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org . Please note that Supporting Information files do not need this step.

Revision 1

Dear Wei Wu,

I hope this message finds you well. We are pleased to submit the revised version of our manuscript entitled “Impact of Perioperative Transesophageal Echocardiogram and Preoperative Echocardiography Waiting Time on Surgical Management in Thailand” (Manuscript Number: PONE-D-25-35063), following the helpful and insightful comments provided by you and the reviewers. We would like to express our sincere gratitude for the constructive feedback, which has significantly improved the quality of our work.

After thorough discussion with our team, we have categorized the comments into items, as outlined below.

Editor’s comments:

1. Although the manuscript suggests that intraoperative TEE was performed in all included cases, this point is not consistently or clearly stated. Given that the primary outcome relates directly to TEE’s influence on surgical planning, it is essential to clearly document the TEE rate and whether it was applied uniformly to all patients. In addition, the manuscript would benefit from more clarity on patient selection, flow, and subgroup structure. For example, it remains somewhat confusing how the subgroups (e.g., TTE-only, TEE-only, or both) were formed, and whether TEE indications were predefined or at the discretion of the care team.

Response: We have revised the manuscript to state explicitly that intraoperative TEE was performed on a cohort representing 74.29% of all cardiac surgeries during the study period; this is now clarified in the first paragraph of the Results section and in the inclusion/exclusion criteria. We have also refined the Methods section under "Study design and subjects" to define the indications for intraoperative TEE, noting that the decision was based on a joint agreement between the attending cardiac anesthesiologist and surgeon.

To address the confusion regarding patient groups, we have clarified that the "TTE-only" and "TTE+TEE" designations refer to preoperative imaging assessments and were analyzed as factors of interest, not as prospectively formed study groups. The revised Figure 1 (Study Flow Diagram) now more clearly illustrates patient selection and flow. Finally, we have standardized the terminology to "intraoperative TEE" throughout the manuscript for consistency.

2. The lack of postoperative outcome analysis limits the ability to fully assess the clinical impact of TEE-guided surgical plan changes. While this may have been outside the original scope, the inclusion of even limited outcome data (e.g., 30-day mortality, complication rates, or length of stay) would substantially strengthen the conclusions and may be feasible from prospective dataset.

Response: We appreciate and agree completely with this valuable suggestion. We have now incorporated a comprehensive analysis of postoperative outcomes through September 2025. This new dataset includes the duration of mechanical ventilation, length of ICU and hospital stays, 30-day mortality, and the incidence of major complications (e.g., atrial fibrillation, reoperation, stroke, acute kidney injury). The Results and Discussion sections have been substantially revised to integrate these findings, providing a more robust assessment of the clinical implications of TEE-guided management changes.

Reviewer’s comments

1. Is the manuscript technically sound, and do the data support the conclusions?

Reviewer #1: Partly

Response: With the addition of the comprehensive postoperative outcomes analysis and the clarifications made in response to all editor and reviewer comments, we believe the manuscript is now technically sound and that the conclusions are more robustly supported by the data.

2. Has the statistical analysis been performed appropriately and rigorously?

Reviewer #1: No

Response: We have re-examined our methodology and confirm that standard, appropriate statistical methods were applied, consistent with the study's prospective observational design and data characteristics, as detailed in the Statistical Analysis section. Based on our best knowledge, we did it appropriately but would be grateful for any specific suggestions for further improvement.

3. Have the authors made all data underlying the findings in their manuscript fully available?

Reviewer #1: Yes

4. Is the manuscript presented in an intelligible fashion and written in standard English?

Reviewer #1: Yes

5. Review Comments to the Author

Reviewer #1: # Summary

1. These investigators conducted a prospective observational study to investigate the impact of intraoperative TEE on surgical planning (primary outcome) and wait times (secondary outcome), among 624 cardiac surgical patients undergoing surgery the calendar year of 2023. They found intraoperative TEE altered the surgical plan in 10% of cases, but did not study clinical outcomes.

# Overall Assessment

1. This is important work on the impact of TEE in a resource-limited situation. However, the absence of investigating TEE's impact on postsurgical outcomes limits the impact and makes this study largely descriptive.

Response: As detailed in our response to the editor (Comment #2), we have now conducted and integrated a full analysis of postoperative clinical outcomes. This addition moves the study beyond a descriptive focus and provides crucial data on the clinical impact of TEE-guided decisions, significantly enhancing the manuscript's contribution.

# Major Issues / Questions

1. what was the overall rate of intraoperative TEE? I see the rate of preoperative TEE was only 15% but I don't see intraoperative TEE reported. If intraoperative TEE was performed in only 15% of cases, there is a major selection bias and residual confounding is likely present. At a minimum matching would be necessary and could consider 1:2 or even 1:3 matching if TEE rate is truly only 15%.

Response: We apologize for the lack of clarity. The 15% rate referred to preoperative TEE. We have now clarified in the Methods and Results sections, as well as in the revised Figure 1, that intraoperative TEE was performed in 624 patients, constituting 74.29% of all cardiac surgeries during the study period. This high rate of utilization strengthens the validity of our findings regarding its impact.

2. While a change in surgical plan is important, it would be stronger if there were an associated postoperative outcomes analysis (e.g. lower rates of reoperation, stroke, complications, death, etc. with TEE)?

Response: As stated in response to editor’s comments and overall assessment of the reviewer’s comments.

# Minor Issues

1. The terminology needs to be consistent. Decide on "perioperative" or "intraoperative" TEE and keep it consistent throughout.

Response: We thank the reviewer for pointing this out. The manuscript has been revised to use the term "intraoperative TEE" consistently throughout.

2. Consider limiting the analysis to intraoperative TEE (instead of adding TTE and the wait times). It starts to become confusing to the reader to interpret.

Response: To streamline the main text, we have moved the detailed results and tables related to preoperative imaging and waiting times into the Supplementary Information. The primary manuscript now focuses more sharply on the impact of intraoperative TEE, while still retaining the waiting time discussion to provide essential context regarding resource limitations in our setting.

6. PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

Reviewer #1: No

We believe that these revisions have strengthened the manuscript, and we hope that the revised version meets the expectations of both you and the reviewers. We look forward to your feedback and hope for a favorable consideration of our submission for publication in PLOS ONE.

Thank you again for your time and consideration.

Sincerely,

Naruenart Lomarat

Attachments
Attachment
Submitted filename: Response to Reviewers.docx
Decision Letter - Wei Wu, Editor

Dear Dr. Lomarat,

Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process.

Please submit your revised manuscript by Jan 03 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org . When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.

  • A rebuttal letter that responds to each point raised by the academic editor and reviewer(s). You should upload this letter as a separate file labeled 'Response to Reviewers'.
  • A marked-up copy of your manuscript that highlights changes made to the original version. You should upload this as a separate file labeled 'Revised Manuscript with Track Changes'.
  • An unmarked version of your revised paper without tracked changes. You should upload this as a separate file labeled 'Manuscript'.

If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols . Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols .

We look forward to receiving your revised manuscript.

Kind regards,

Wei Wu

Academic Editor

PLOS ONE

Journal Requirements:

If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise.

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Additional Editor Comments (if provided):

There some minor points:

1, The Discussion suggests that TEE-guided changes may have mitigated higher intrinsic surgical risk and therefore resulted in similar postoperative outcomes between groups. This is a causal inference that is not supported by the study design, because all patients received intraoperative TEE and no control group exists for comparison. Please rephrase sentences to avoid implying that intraoperative TEE reduced postoperative risk.

2, Although the TTE+TEE group had significantly longer preoperative waiting times, the manuscript states that “disease severity may evolve during the waiting period.” However, the data do not show that waiting time independently contributed to surgical management changes. Please clarify the interpretation by avoiding language that implies a causal relationship (e.g., “waiting time leads to disease progression”). This is important for preventing overinterpretation.

3, Although improved, several sections still contain grammatical issues (like "preoperative TTEalone group"). Please have a final round of careful English editing is recommended to ensure clarity and professionalism.

[Note: HTML markup is below. Please do not edit.]

Reviewers' comments:

Reviewer's Responses to Questions

Comments to the Author

Reviewer #1: All comments have been addressed

**********

2. Is the manuscript technically sound, and do the data support the conclusions??>

Reviewer #1: Yes

**********

3. Has the statistical analysis been performed appropriately and rigorously? -->?>

Reviewer #1: Yes

**********

4. Have the authors made all data underlying the findings in their manuscript fully available??>

The PLOS Data policy

Reviewer #1: Yes

**********

5. Is the manuscript presented in an intelligible fashion and written in standard English??>

Reviewer #1: Yes

**********

Reviewer #1: My reviewer comments have been adequately addressed. .......................................................................

**********

what does this mean? ). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy

Reviewer #1: No

**********

[NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.]

To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures

You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation.

NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications.

Revision 2

Dear Wei Wu,

We are pleased to submit the revised version of our manuscript, “Impact of Intraoperative Transesophageal Echocardiogram on Changes in Surgical Management among Patients Undergoing Cardiovascular Surgery in Thailand” (Manuscript Number: PONE-D-25-35063R1). We would like to express our sincere gratitude for the constructive feedback and helpful comments provided, which have significantly improved the quality of our work

Editor’s comments:

1, The Discussion suggests that TEE-guided changes may have mitigated higher intrinsic surgical risk and therefore resulted in similar postoperative outcomes between groups. This is a causal inference that is not supported by the study design, because all patients received intraoperative TEE and no control group exists for comparison. Please rephrase sentences to avoid implying that intraoperative TEE reduced postoperative risk.

Response: Thank you for raising this important and subtle point, reflecting the meticulous review provided. To address this issue, we have carefully revised the Discussion to adopt a more conservative tone, focusing on associations rather than causal links. We have also explicitly stated the limitations of interpreting these results due to the observational study design and the absence of a control group for comparison, both in the Discussion and the Limitations section.

Changes in the Manuscript:

From: “TEE-guided interventions likely identified and corrected unanticipated findings in patients with more complex or severe pathology, thereby mitigating higher inherent risks and yielding outcomes similar to those in the less complex “no-change” group.”

To: “Intraoperative TEE facilitated the identification of unanticipated findings in patients with complex or severe pathology. While postoperative outcomes were similar between the 'change' and 'no-change' groups, the observational study design and the universal use of intraoperative TEE preclude a direct assessment of whether these modifications prevented adverse outcomes.”

Added to the final paragraph of the Discussion: “Furthermore, the current study was not designed to establish a direct causal link between these modifications and a reduction in postoperative risk, or it may be that such benefits are not fully reflected in short-term postoperative metrics.”

2, Although the TTE+TEE group had significantly longer preoperative waiting times, the manuscript states that “disease severity may evolve during the waiting period.” However, the data do not show that waiting time independently contributed to surgical management changes. Please clarify the interpretation by avoiding language that implies a causal relationship (e.g., “waiting time leads to disease progression”). This is important for preventing overinterpretation.

Response: We appreciate this guidance to avoid overinterpretation of the relationship between waiting times and clinical evolution. We have revised this section of the Discussion to ensure our conclusions remain strictly aligned with our data. Specifically, we have removed language implying a causal link between waiting time and disease progression and instead report the findings as a lack of independent association in our multivariable analysis.

Changes in the Manuscript:

From: “These findings may suggest that disease severity and case complexity were already well-accounted for in surgical scheduling. Nonetheless, disease status may continue to evolve during the preoperative period, particularly in complex cases. This assumption is supported by the findings in S2 Table, which show no significant differences in waiting times between patients with and without management changes, in both the TTE-only and TTE with TEE subgroups. Still, the waiting time is a risk factor for morbidity and mortality outcomes after cardiac surgery.”

To: “While disease status may potentially evolve during the preoperative period, particularly in complex cases, this data showed no significant difference in waiting times between patients with and without management changes in either the preoperative TTE alone or preoperative TTE combined with TEE subgroups (S2 Table). These findings suggest that, in this study, waiting time was not independently associated with surgical management changes, though it remains a known risk factor for morbidity and mortality after cardiac surgery [19, 20].”

3, Although improved, several sections still contain grammatical issues (like "preoperative TTEalone group"). Please have a final round of careful English editing is recommended to ensure clarity and professionalism.

Response: We sincerely appreciate the Editor’s feedback regarding the manuscript's presentation. To ensure a high standard of clarity and professionalism, the entire manuscript has undergone a final round of meticulous English language editing. We have specifically focused on:

• Terminology Consistency: We have standardized all terms throughout the manuscript. The preoperative groups are now consistently referred to as the "preoperative TTE alone group" and the "preoperative TTE combined with TEE group." The intraoperative assessment is consistently termed "intraoperative TEE."

• Typo error: We have corrected all spacing issues (e.g., "TTEalone") and ensured that mathematical symbols and ranges use the appropriate formatting.

• Grammatical Integrity: The manuscript was reviewed for grammatical accuracy using Gemini (Google) for initial identification of potential errors, followed by extensive manual editing and expert review to ensure technical and clinical precision. While we believe the text is now clear and professionally polished, we remain available for further refinement should any minor stylistic points remain.

• We have conducted a thorough audit of the reference list to ensure accuracy, technical consistency, and full compliance with PLOS ONE guidelines. This process included cross-referencing all citations against retraction databases to confirm that no retracted works are included in the manuscript. Additionally, we carefully evaluated all reviewer-suggested literature, incorporating those publications that provided relevant academic context to enhance our study’s discussion. All references have been verified for correct formatting and are accurately cited within the text.

Reviewer’s comments

All comments have been adequately addressed

We believe these revisions have significantly strengthened the manuscript and hope the revised version now meets the expectations of the Editor and the reviewers. We look forward to your decision and thank you once again for your time and thoughtful consideration of our work.

Sincerely,

Naruenart Lomarat

Attachments
Attachment
Submitted filename: Response_to_Reviewers_auresp_2.docx
Decision Letter - Wei Wu, Editor

Impact of Intraoperative Transesophageal Echocardiogram on Changes in Surgical Management among Patients Undergoing Cardiovascular Surgery in Thailand

PONE-D-25-35063R2

Dear Dr. Lomarat,

We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements.

Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication.

An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager®  and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support .

If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

Kind regards,

Wei Wu

Academic Editor

PLOS One

Additional Editor Comments (optional):

The aruthors have fully addressed all concerns.

Reviewers' comments:

Formally Accepted
Acceptance Letter - Wei Wu, Editor

PONE-D-25-35063R2

PLOS One

Dear Dr. Lomarat,

I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team.

At this stage, our production department will prepare your paper for publication. This includes ensuring the following:

* All references, tables, and figures are properly cited

* All relevant supporting information is included in the manuscript submission,

* There are no issues that prevent the paper from being properly typeset

You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps.

Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org.

You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing.

If we can help with anything else, please email us at customercare@plos.org.

Thank you for submitting your work to PLOS ONE and supporting open access.

Kind regards,

PLOS ONE Editorial Office Staff

on behalf of

Dr. Wei Wu

Academic Editor

PLOS One

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .